We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.49B
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+12.64%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.58%
5 Year Est. Return
+121.05%
10 Year Est. Return
+327.07%
AUM
$892M
AUM Growth
-$3.65B
Cap. Flow
-$3.98B
Cap. Flow %
-446.06%
Top 10 Hldgs %
42.63%
Holding
288
New
30
Increased
21
Reduced
76
Closed
95

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$294M
2
OXY icon
Occidental Petroleum
OXY
+$208M
3
T icon
AT&T
T
+$199M
4
INTC icon
Intel
INTC
+$195M
5
GM icon
General Motors
GM
+$187M

Sector Composition

Rank Sector Weight
1 Financials 18.44%
2 Healthcare 12.97%
3 Technology 12.9%
4 Communication Services 9.23%
5 Energy 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVGS icon
176
Navigator Holdings
NVGS
$1.25B
$121K 0.01%
11,000
WIW
177
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$510M
$119K 0.01%
11,070
AQMS icon
178
Aqua Metals
AQMS
$9.7M
$115K 0.01%
187
-179
-49% -$99.2K
INO icon
179
Inovio Pharmaceuticals
INO
$76.1M
$112K 0.01%
+2,500
New +$126K
BKS
180
DELISTED
Barnes & Noble
BKS
$109K 0.01%
20,000
-30,000
-60% -$183K
AIG.WS
181
DELISTED
American International Group, Inc.
AIG.WS
$106K 0.01%
18,898
AMRS
182
DELISTED
Amyris Inc.
AMRS
$104K 0.01%
+50,000
New +$197K
AVP
183
DELISTED
Avon Products, Inc.
AVP
$96K 0.01%
32,800
DHF
184
BNY Mellon High Yield Strategies Fund
DHF
$172M
$92K 0.01%
30,000
MXWL
185
DELISTED
Maxwell Technologies Inc
MXWL
$89K 0.01%
+20,000
New +$78.6K
PAVMZ
186
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$87K 0.01%
225,262
+18,262
+9% +$6.43K
BW icon
187
Babcock & Wilcox
BW
$1.32B
$41K ﹤0.01%
+10,000
New +$54.9K
ACH
188
Accendra Health
ACH
$107M
$41K ﹤0.01%
+10,000
New +$63.2K
GTYHW
189
DELISTED
GTY Technology Holdings, Inc. Warrants
GTYHW
$30K ﹤0.01%
50,000
PAVM icon
190
PAVmed
PAVM
$34M
$27K ﹤0.01%
+56
New +$25.6K
ACHC icon
191
Acadia Healthcare
ACHC
$2.96B
-15,000
Closed -$386K
AUPH icon
192
Aurinia Pharmaceuticals
AUPH
$2.06B
-10,000
Closed -$68K
AVNT icon
193
Avient
AVNT
$4.19B
-7,000
Closed -$200K
AXTA icon
194
Axalta
AXTA
$8.01B
-18,471
Closed -$433K
BALL icon
195
Ball Corp
BALL
$16.6B
-10,000
Closed -$460K
BC icon
196
Brunswick
BC
$5.21B
-28,914
Closed -$1.34M
BIO icon
197
Bio-Rad Laboratories Class A
BIO
$9.48B
-569,205
Closed -$132M
BKR icon
198
Baker Hughes
BKR
$63.6B
-18,900
Closed -$406K
BKU icon
199
Bankunited
BKU
$3.3B
-127,062
Closed -$3.8M
BLK icon
200
Blackrock
BLK
$175B
-4,000
Closed -$1.57M

Similar funds

Levin Capital Strategies's Q1 2019 Portfolio in Review

As of Q1 2019, Levin Capital Strategies held 288 positions worth $892M, down 80% from $4.54B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Levin Capital Strategies withdrew a net $3.98B in Q1 2019, closing 95 positions and reducing 76 holdings. Its most notable exit was Treehouse Foods, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Levin Capital Strategies opened a new position in Fox Class B worth $1.1M.

  • Levin Capital Strategies's largest Q1 2019 buy was Fox Class B: 30,536 shares worth $1.1M.
  • Levin Capital Strategies added most to Walt Disney in Q1 2019, an estimated $12.5M increase.
  • Levin Capital Strategies's biggest Q1 2019 reduction was DuPont de Nemours, cutting an estimated $294M.
  • Levin Capital Strategies fully exited Treehouse Foods in Q1 2019, selling an estimated $167M.
  • Levin Capital Strategies's ten largest holdings make up 43% of its $892M portfolio in Q1 2019.
  • Levin Capital Strategies opened 30 new positions and closed 95 in Q1 2019.
  • Levin Capital Strategies's portfolio value fell 80% quarter-over-quarter to $892M.

Based on Levin Capital Strategies's 13F filing for Q1 2019, filed 13 May 2019.